Delivery Order SPE2DB22D3501-SPE2DB25FXB92
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a ceiling value of $1,159.29. This firm fixed-price delivery order, which is set to be completed by August 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involved no...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,524.88 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,060.46 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a small-value pharmaceutical delivery under the company's larger federal contract portfolio. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,335.49 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.78 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order and functions as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a $2,687.81 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Kerendia 10 mg, a pharmaceutical product used in the treatment of chronic kidney disease. This competitively awarded, firm fixed-price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...